Cuprina Holdings (Cayman) Limited
$0.33
▲
1.8%
2026-04-21 06:18:00
www.cuprina.com.sg
NCM: CUPR
Explore Cuprina Holdings (Cayman) Limited stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$2.47 M
Current Price
$0.33
52W High / Low
$9.5 / $0.28
Stock P/E
—
Book Value
$0.28
Dividend Yield
—
ROCE
34.48%
ROE
-1.39%
Face Value
—
EPS
$-0.11
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
14
Beta
—
Debt / Equity
40.86
Current Ratio
3.58
Quick Ratio
0.27
Forward P/E
—
Price / Sales
248.93
Enterprise Value
$6.51 M
EV / EBITDA
-2.32
EV / Revenue
214.74
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
Cons
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Utah Medical Products, Inc. | $70.22 | 20.02 | $225.9 M | 1.77% | 9.51% | 9.54% | $71.81 / $51.26 | $37.43 |
| 2. | Stereotaxis, Inc. | $1.98 | — | $192.55 M | — | -73.98% | -1.44% | $3.59 / $1.74 | $0.14 |
| 3. | Stevanato Group S.p.A. | $15.86 | 26.32 | $4.33 B | 0.39% | 9.9% | 9.67% | $28 / $12.89 | $6.28 |
| 4. | NEXGEL, Inc. | $0.64 | — | $6.98 M | — | -41.75% | -52.74% | $2.99 / $0.56 | $0.64 |
| 5. | Align Technology, Inc. | $194.19 | 34.46 | $14 B | — | 13.57% | 10.39% | $208.31 / $122 | $56.74 |
| 6. | Ekso Bionics Holdings, Inc. | $11.38 | — | $40.55 M | — | -116.13% | -1.08% | $13.5 / $2.73 | $2.54 |
| 7. | Regentis Biomaterials Ltd. | $2.96 | — | — | — | -181.68% | 75.07% | $8.35 / $2.8 | $0.92 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Sales | 0.05 M | 0.1 M | 0.06 M | 0.06 M |
| Operating Profit | -1.48 M | -1.03 M | -1.12 M | -0.52 M |
| Net Profit | -1.56 M | -1.12 M | -1.09 M | -0.52 M |
| EPS in Rs | -0.21 | -0.15 | -0.15 | -0.07 |
Balance Sheet
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Total Assets | 1.75 M | 1.59 M | 1.44 M | 0.95 M |
| Total Liabilities | 6.2 M | 4.48 M | 3.21 M | 1.64 M |
| Equity | -4.46 M | -2.9 M | -1.78 M | -0.68 M |
| Current Assets | 1.66 M | 1.44 M | 1.27 M | 0.81 M |
| Current Liabilities | 6.04 M | 4.43 M | 3.09 M | 1.51 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | -1.24 M | -0.89 M | -1.85 M | -0.22 M |
| Investing CF | -0.02 M | -0.07 M | -0.03 M | -0 M |
| Financing CF | 1.34 M | 0.43 M | 1.68 M | 0.99 M |
| Free CF | -1.26 M | -0.96 M | -1.87 M | -0.22 M |
| Capex | -0.02 M | -0.07 M | -0.02 M | -0 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -52.05% | 78.05% | -3.26% | — |
| Earnings Growth % | -39.39% | -2.29% | -110.61% | — |
| Profit Margin % | -3229.52% | -1110.97% | -1933.81% | -888.29% |
| Operating Margin % | -3065.77% | -1024.32% | -1987.17% | -885.52% |
| Gross Margin % | -6.26% | 36.32% | 35.3% | 39.41% |
| EBITDA Margin % | -2957.74% | -986.5% | -1865.87% | -836.6% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.